This project has led to significant academic and policy outputs. Overall, the lead Principal Investigator, Prof Susi Geiger, and project members published 37 journal publications in highly ranked international journals (Impact Factors ranging from 2.3 to 10.8) associated with their work on this project. Prof Susi Geiger also published two edited volumes and one monograph: "Healthcare Activism: Markets, Morals and the Collective Good" (Oxford University Press, 2021); "Market Studies: Mapping, Theorizing and Impacting Market Action" (Cambridge University Press, Octobeer 2024) and "Peak Pharma: Toward a new pharmaceutical political economy" (Oxford University Press, April 2025). Beyond these academic outputs, the project has led to 51 conference papers, 7 conference tracks, 9 project workshops and events, 2 public exhibitions, 18 project blogs and several public policy interventions, including four papers on the website publicpolicy.ie. As the project included a participatory design, Prof Susi Geiger has also deeply engaged with the advocacy groups Access to Medicines Ireland, Public Pharma for Europe and Digital Rights Ireland. Overall, these outputs construct a detailed and empirically grounded framework of activism in medical markets. They clearly demonstrate how researchers can engage with activists to challenge many of the received beliefs in pharmaceutical markets.